摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

S-(4-氯苄基)氯化异硫脲 | 544-47-8

中文名称
S-(4-氯苄基)氯化异硫脲
中文别名
——
英文名称
S-(4-chlorobenzyl)isothiourea hydrochloride
英文别名
[C-[(4-chlorophenyl)methylsulfanyl]carbonimidoyl]azanium;chloride
S-(4-氯苄基)氯化异硫脲化学式
CAS
544-47-8
化学式
C8H9ClN2S*ClH
mdl
——
分子量
237.153
InChiKey
QAVHMIYSTFZJAU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    200-202°C
  • 密度:
    1.4757 (rough estimate)
  • 稳定性/保质期:

    按规格使用和贮存,不会发生分解,避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    2.89
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    75.2
  • 氢给体数:
    3
  • 氢受体数:
    2

安全信息

  • TSCA:
    Yes
  • 安全说明:
    S24/25
  • 海关编码:
    2930909090
  • 储存条件:
    储存于阴凉、干燥、通风良好的库房。远离火种和热源,防止阳光直射,并将包装密封。与酸类和食用化学品分开存放,切忌混储。储区应备有合适的材料以处理泄漏物。

SDS

SDS:39872366d3ca57f8d61d47bec30b8161
查看
Name: S-(4-Chlorobenzyl)-Thiuronium Chloride 99+% Material Safety Data Sheet
Synonym: P-Chlorobenzylpseudothiuronium Chloride
CAS: 544-47-8
Section 1 - Chemical Product MSDS Name:S-(4-Chlorobenzyl)-Thiuronium Chloride 99+% Material Safety Data Sheet
Synonym:P-Chlorobenzylpseudothiuronium Chloride

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
544-47-8 Carbamimidothioic Acid, (4-Chloropheny 99+ 208-871-0
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 544-47-8: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 205 - 207 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H10Cl2N2S
Molecular Weight: 237.15

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide, hydrogen sulfide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 544-47-8: UM0950000 LD50/LC50:
Not available.
Carcinogenicity:
Carbamimidothioic Acid, (4-Chlorophenyl)methylester, Monohyd - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 544-47-8: No information available.
Canada
CAS# 544-47-8 is listed on Canada's NDSL List.
CAS# 544-47-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 544-47-8 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

类别:有毒物质

毒性分级:中毒

急性毒性(口服-小鼠):LDL0 1600 毫克/公斤

可燃性危险特性:热分解排出有毒的氮氧化物、硫氧化物、氯化物及氯化氢烟雾

储运特性:库房应低温通风干燥保存

灭火剂:水、二氧化碳、泡沫、干粉

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    P2Y12拮抗剂乙基6-(4-((苯甲磺酰基)氨基甲酰基)哌啶-1-基)-5-氰基-2-甲基烟酸酯(AZD1283)的优化导致发现具有改善的类药物特性的口服抗血小板药。
    摘要:
    P2Y12拮抗剂广泛用作预防和治疗动脉血栓形成的抗血小板药。基于已知的P2Y12拮抗剂AZD1283的支架,设计和合成了一系列新型的双环吡啶衍生物。吡啶环上的酯取代基与邻甲基的环化作用导致AZD1283的内酯类似物在随后的结构-药代动力学关系研究中显示出显着增强的代谢稳定性。通过向哌啶基部分添加4-甲基取代基进一步增强了代谢稳定性。在大鼠氯化铁模型中,化合物58l在体外显示出对血小板聚集的有效抑制以及抗血栓形成的功效。而且,58l显示出的安全性优于在大鼠尾巴出血模型中观察到的氯吡格雷的安全性。这些结果支持进一步评价化合物58l作为有前途的候选药物。
    DOI:
    10.1021/acs.jmedchem.8b01971
  • 作为产物:
    描述:
    4-氯苯甲醇氯化亚砜 作用下, 以 吡啶乙醇 为溶剂, 反应 4.0h, 生成 S-(4-氯苄基)氯化异硫脲
    参考文献:
    名称:
    抗高血脂的N-苄基氨基磺酸盐,N-苄基氨基磺酸盐和苄基磺酰胺的结构活性研究
    摘要:
    已经制备了一系列芳基取代的N-苯甲酰基-和N-苄基氨基磺酸钠盐和苄基磺酰胺钠盐,并以20 mg / kg / d ip ip水平在雄性CF1小鼠中检测了16 d的降血脂活性。这些物质也接受了毒理学评估和化学稳定性研究。通常,氨基磺酸盐和磺酰胺都显着降低了小鼠的血清胆固醇和甘油三酸酯水平。该化合物是非致突变性的,在雄性小鼠中没有显示出急性毒性或肝或肾功能受损,并且在3.5-7.4的pH范围内,作为一水合物和水溶液都具有化学稳定性。虽然这一系列的氨基磺酸盐和磺酰胺盐都降低了血清胆固醇和甘油三酸酯的水平,
    DOI:
    10.1002/jps.2600730321
点击查看最新优质反应信息

文献信息

  • Clean and Economic Synthesis of Alkanesulfonyl Chlorides from S-Alkyl Isothiourea Salts via Bleach Oxidative Chlorosulfonation
    作者:Jiaxi Xu、Zhanhui Yang、Bingnan Zhou
    DOI:10.1055/s-0033-1338567
    日期:——
    Abstract A simple procedure for clean and economic synthesis of alkanesulfonyl chlorides via bleach-mediated oxidative chlorosulfonation of S-alkyl isothiourea salts is disclosed. This procedure is environment- and worker-friendly with the advantages of readily accessible materials and reagents, simple and safe operations, easy purification without chromatography, and affords high yields of up to 99%
    摘要 公开了通过漂白介导的S-烷基异硫脲盐的氧化氯磺化来清洁和经济地合成烷烃磺酰氯的简单方法。该方法对环境和工人均有利,具有易于获得的材料和试剂,简单安全的操作,无需色谱法即可轻松纯化的优点,并提供高达99%的高收率。 公开了通过漂白介导的S-烷基异硫脲盐的氧化氯磺化来清洁和经济地合成烷烃磺酰氯的简单方法。该方法对环境和工人均有利,具有易于获得的材料和试剂,简单安全的操作,无需色谱法即可轻松纯化的优点,并提供高达99%的高收率。
  • tert-Butyl Hypochlorite Mediated Oxidative Chlorination of S-Alkylisothiourea Salts: Synthesis of Sulfonyl Chlorides
    作者:Kui Qiu、Rennan Wang
    DOI:10.1055/s-0034-1381024
    日期:——
    Cbz-protecting group was not affected. Under neutral conditions, a variety of S-alkylisothiourea salts were smoothly converted into the corresponding sulfonyl chlorides through tert-butyl chlorite mediated oxidative chlorination in good to excellent yields after simple purification. In addition to the environmental and procedural advantages of this method, the neutral conditions potentially make it applicable
    摘要 在中性条件下,通过简单的纯化后,通过亚氯酸叔丁酯介导的氧化氯化,将各种S-烷基异硫脲盐平稳地转化为相应的磺酰氯。除了此方法的环境和程序优势外,中性条件还可能使其适用于带有酸敏感官能团的底物。例如,在当前的中性条件下,可以中等至良好的产率合成Cbz保护的2-氨基乙烷磺酰氯,并且酸敏感的Cbz保护基不受影响。 在中性条件下,通过简单的纯化后,通过亚氯酸叔丁酯介导的氧化氯化,将各种S-烷基异硫脲盐平稳地转化为相应的磺酰氯。除了此方法的环境和程序优势外,中性条件还可能使其适用于带有酸敏感官能团的底物。例如,在当前的中性条件下,可以中等至良好的产率合成Cbz保护的2-氨基乙烷磺酰氯,并且酸敏感的Cbz保护基不受影响。
  • Synthesis of difluoromethyl and deuterium-labeled difluoromethyl thioethers from aliphatic electrophiles
    作者:Tianqi Ding、Lvqi Jiang、Wenbin Yi
    DOI:10.1039/c9cc09709k
    日期:——
    described. The transition-metal-free approach, readily available reagents, and mild conditions provide a practical way for the synthesis of difluoromethyl thioethers. By changing the “H” source to the most commonly used “D” sources CD3OD and D2O, this strategy enables efficient synthesis of SCF2D-substituted molecules in good yields with high levels of D incorporation.
    描述了烷基亲电试剂与硫脲和溴代二氟甲基膦酸二乙酯的一锅二氟甲基硫醇化。不含过渡金属的方法,容易获得的试剂和温和的条件为合成二氟甲基硫醚提供了一种实用的方法。通过将“ H”源更改为最常用的“ D”源CD 3 OD和D 2 O,此策略能够以高收率和高D掺入量高效合成SCF 2 D取代分子。
  • Design, synthesis and biological evaluation of novel N-sulfonylamidine-based derivatives as c-Met inhibitors via Cu-catalyzed three-component reaction
    作者:Xiang Nan、Jing Zhang、Hui-Jing Li、Rui Wu、Sen-Biao Fang、Zhi-Zhou Zhang、Yan-Chao Wu
    DOI:10.1016/j.ejmech.2020.112470
    日期:2020.8
    In our continuing efforts to develop novel c-Met inhibitors as potential anticancer candidates, a series of new N-sulfonylamidine derivatives were designed, synthesized via Cu-catalyzed multicomponent reaction (MCR) as the key step, and evaluated for their in vitro biological activities against c-Met kinase and four cancer cell lines (A549, HT-29, MKN-45 and MDA-MB-231). Most of the target compounds
    在我们不断努力开发新颖的c-Met抑制剂作为潜在的抗癌候选药物的过程中,设计了一系列新的N-磺酰lam啶衍生物,并通过Cu催化的多组分反应(MCR)合成了关键步骤,并对它们的体外生物学活性进行了评估。抗c-Met激酶和四种癌细胞系(A549,HT-29,MKN-45和MDA-MB-231)。大多数目标化合物在基于酶和基于细胞的测定中均显示出中等至显着的效力,并且对A549和HT-29癌细胞系具有选择性。SAR的初步研究表明,化合物26af(c-Met IC 50 与阳性的foretinib相比,它具有2.89 nM)的最有前途的化合物,后者具有显着的抗增殖活性,IC 50值为0.28至0.72μM。对26af的机理研究表明,抗癌活性与c-Met的阻断磷酸化密切相关,导致细胞周期停滞在G2 / M期,并以浓度依赖的方式导致A549细胞凋亡。有希望的化合物26af被进一步鉴定为c-Met激酶的相对选择性抑制剂,在BALB
  • PDE4B inhibitors and uses therefor
    申请人:Ibrahim N. Prabha
    公开号:US20060041006A1
    公开(公告)日:2006-02-23
    Compounds active on phosphodiesterase PDE4B are provided. Also provided herewith are compositions useful for treatment of PDE4B-mediated diseases or conditions, and methods for the use thereof.
    提供对磷酸二酯酶PDE4B活性的化合物。还提供了用于治疗PDE4B介导的疾病或症状的组合物,以及其使用方法。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐